Hanmi Pharm Q1 net profit down 33 pct. to 12 bln won
SEOUL, April 28 (Yonhap) -- Hanmi Pharm. Co. on Tuesday reported its first-quarter net profit of 11.5 billion won (US$ 9.4 million), down 33.4 percent from a year earlier.
The company said in a regulatory filing that operating income for the January-March period rose 10.8 percent on-year to 28.7 billion won. Revenue increased 4.9 percent to 288.2 billion won.
The operating profit was 15.1 percent higher than the average estimate, according to the survey by Yonhap Infomax, the financial data firm of Yonhap News Agency. The estimate of net profit was not available.
※ This article was generated by Yonhap's proprietary algorithm using data from Yonhap Infomax and Korea Exchange(KRX).
(END)
-
S. Korea to resume issuing short-term travel visas, e-visas next month
-
Ateez to drop new Japanese EP next week
-
(2nd LD) BTS wins three Billboard Music Awards, marking 6th year to win an award
-
Crypto investor probed over allegedly visiting house of Terraform's CEO
-
(2nd LD) N. Korea still unresponsive to S. Korea's outreach for talks on COVID-19: official
-
S. Korea to resume issuing short-term travel visas, e-visas next month
-
(LEAD) Yoon, PPP lawmakers travel to Gwangju en masse to commemorate 1980 democracy uprising
-
(5th LD) Yoon, Biden agree to expand joint military exercises to cope with N.K. threats
-
(LEAD) At least 8 injured in S-Oil refinery explosion in Ulsan: firefighters
-
(LEAD) Biden set to arrive in S. Korea for first summit with Yoon
-
First lady Kim to greet Biden before state dinner
-
(5th LD) Yoon, Biden agree to expand joint military exercises to cope with N.K. threats
-
(2nd LD) Yoon, Biden hold first summit on N. Korea, economy
-
Biden calls Moon 'good friend' in phone conversation: Moon's aide
-
Full text of joint statement issued after Yoon-Biden summit